Replies to post #225399 on Innovation Pharmaceuticals Inc (IPIX)

[frrol]

I believe so too. I suspect there was embarrassing confusion with the CRO, and the company decided to just let it drop, believing that was the best course of action. Transparency is important, and this management has been terrifically transparent with the exception of this. Which is why it is puzzling.

[farrell90]

I agree. The CRO most likely advised IPIX to not release the interim report.

The CRO may not have been aware of Mr Ehrlich's promise to release the results, but when they were made aware they advised against it for the reasons outlined by Plenty and others.

JMO ,but I do not think it is a big deal. In fact it appears IPIX most likely had been preparing an interim report and it was favorable enough for the company to push forward the completion of the 2B study.

I am looking forward to the release of the final results from the 2B study. Hopefully Prurisol's development with the aid of the 505b designation will be accelerated.

My bet is the results will be good; but if they are not, and the company decides to not go forward with Prurisol. IPIX will move forward with a deal for Brilacidin.

IPIX's chance of success is better than a coin toss. Heads we win with Prurisol and Brilacidin. Tails we win with Brilacidin.

IPIX shareholders win either way and I am freeing up funds to buy more shares. I never buy on margin.

JMO Farrell